According to a survey from the Association for Corporate Growth, 62% of small and medium-sized businesses majority-owned by venture capital, private equity or other private capital providers are excluded from the Paycheck Protection Program.
The New York chapter of the Association for Corporate Growth, the largest association of middle-market deal making professionals in New York, hired a new Executive Director, Vikash Magdani.
In a statement, Gary A. LaBranche, president and CEO of the Association for Corporate Growth, vowed to work with the new Congress and administration to support middle market growth.
Mackinac Partners was recognized with a 2014 Champions Award from ACG and The M&A Advisor for its role as restructuring financial advisor and chief restructuring officer to AgFeed Industries.
ACG Atlanta recognized LocumTenens.com as part of its 2014 Georgia Fast 40, which identifies the top 40 fastest growing middle-market companies in Georgia.
The ACG is partnering with online networker Axial to better connect the middle market. The collaboration will, among other things, allow the pair to enhance their shared goal of enabling private companies with more access to capital.
The Association for Corporate Growth said it applauds the decision of the Division of Investment Management of the SEC for providing much-needed relief from the requirement of the custody rule.
CRGT and Veritas Capital were recognized with the 2013 Corporate Growth Award for Private Equity Deal of the Year by the National Capital Chapter of the Association for Corporate Growth
Welcome to InterGrowth® 2013 The strength of the ACG Global network is showcased at InterGrowth, where attendees experience firsthand the business-building power of the ACG community. Maximizing your time away from the office, this highly praised event provides you with the opportunity to network with 2,000 professionals from the M&A “ecosystem:” private equity firms, […]
Please join ACG New York (in Westchester/Hudson Valley) for our Biotech Breakfast. Our panel is comprised of experts who represent both the operating company and funding side of today’s rapidly evolving biotechnology industry. With the Nasdaq Biotechnology Index hovering near all-time highs, we expect to have a lively and interactive debate over the current status […]